Cost-effective prevention of cardiovascular disease in developing countries
Cost-effective prevention of cardiovascular disease in developing countries
批准号:
7758285
负责人:
THOMAS A GAZIANO
金额:
$12.31万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-01 至 2011-11-30
关键词:
AfricanAgeAreaBlood PressureBlood TestsBlood specimenCardiovascular DiseasesCardiovascular systemCaringCessation of lifeCholesterolCosts and BenefitsCox Proportional Hazards ModelsDataDatabasesDemographic and Health SurveysDeveloping CountriesDevelopmentDiabetes MellitusEventFutureGoalsGuidelinesHealthHumanHypertensionIndiaInternationalLaboratoriesLipidsMeasuresMentored Research Scientist Development AwardModelingObesityPhysiciansPopulationPredictive ValuePrevalencePrevention strategyProcessResearchResearch PersonnelResearch ProposalsResourcesRiskRisk FactorsSamplingScreening procedureSentinel SurveillanceSouth AfricaTestingTobaccoTrainingUnited StatesWomen&aposs HealthWorkbasecardiovascular disorder preventioncardiovascular disorder riskcareercohortcostcost effectivenesshigh riskpublic health relevancetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cost-effective prevention of cardiovascular disease (CVD) is necessary to avert significant suffering and death in developing countries. The purpose of this International Research Scientist Development Award is to prepare the applicant, Thomas A Gaziano, for a career as an independent investigator in cost-effective CVD prevention in developing countries. Current international guidelines assess risk of CVD on the basis of multiple risk factors including cholesterol and diabetes status. However, the cost of blood testing and a lack of trained staff to obtain samples make these guidelines unsustainable in developing countries. Further, it is unclear how much added information blood sampling provides to other easily obtainable risk factors. Dr. Gaziano proposes a three-year training and research proposal to continue the development of a simple bloodless screening tool for predicting those at highest risk for CVD and then to assess the cost effectiveness of such a strategy in two very different developing countries. The research plan consists of two specific aims. 1. To assess the predictive value of a set of easily obtainable risk factors for CVD --age, tobacco, systolic blood pressure, and an obesity measure (BMI)~ and compare it to the more commonly used model that uses age, tobacco status, blood pressure, lipids and diabetes status. The analysis will be conducted with the Women's Health Study and Physician's Health databases using Cox-proportional hazard modeling. 2. To conduct a cost-effective analysis of screening for CVD using the following strategies: screening without blood sampling, screening with blood sampling, and a third strategy of a two step process of first assessing risk with no blood testing to identify a subset of the population who might benefit from higher cost screening with blood testing. This analysis will be based in part on cost and risk factor prevalence data in the Sentinel Surveillance for CVD in India Study and the Demographic and Health Survey in South Africa. PUBLIC HEALTH RELEVANCE: Eighty percent of cardiovascular deaths occur in developing countries. Assessing those at high risk is an important strategy for prevention. Developing countries have limited resources for strategies that require laboratory testing. We conducted a study to determine if a non laboratory-based risk prediction tool could perform as well as one requiring laboratory information.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Implementation of a Combination Intervention for Sustainable Blood Pressure Control in Rural KwaZulu-Natal, South Africa (IMPACT-BP)
-
批准号:9884873
-
项目类别:
-
资助金额:$60.52万
-
财政年份:2020
-
负责人:THOMAS A GAZIANO
-
依托单位:
Implementation of a Combination Intervention for Sustainable Blood Pressure Control in Rural KwaZulu-Natal, South Africa (IMPACT-BP)
-
批准号:10688172
-
项目类别:
-
资助金额:$55.4万
-
财政年份:2020
-
负责人:THOMAS A GAZIANO
-
依托单位:
PRIMECare Trial: Preventing Ischemic Heart Disease with mHealth, electronic decision support, and Community Health Workers.
-
批准号:10627833
-
项目类别:
-
资助金额:$62.37万
-
财政年份:2020
-
负责人:THOMAS A GAZIANO
-
依托单位:
Implementation of a Combination Intervention for Sustainable Blood Pressure Control in Rural KwaZulu-Natal, South Africa (IMPACT-BP)
-
批准号:10254224
-
项目类别:
-
资助金额:$57.63万
-
财政年份:2020
-
负责人:THOMAS A GAZIANO
-
依托单位:
PRIMECare Trial: Preventing Ischemic Heart Disease with mHealth, electronic decision support, and Community Health Workers.
-
批准号:10451716
-
项目类别:
-
资助金额:$62.21万
-
财政年份:2020
-
负责人:THOMAS A GAZIANO
-
依托单位:
PRIMECare Trial: Preventing Ischemic Heart Disease with mHealth, electronic decision support, and Community Health Workers.
-
批准号:10223432
-
项目类别:
-
资助金额:$61.77万
-
财政年份:2020
-
负责人:THOMAS A GAZIANO
-
依托单位:
MHealth interventions to improve access and coverage of uninsured people with high cardiovascular risk in Argentina
-
批准号:9206906
-
项目类别:
-
资助金额:$16.11万
-
财政年份:2016
-
负责人:THOMAS A GAZIANO
-
依托单位:
CARDIOMETABOLIC DISEASE & RISK FACTORS AMONG OLDER ADULTS IN SUB-SAHARAN AFRICA
-
批准号:8589166
-
项目类别:
-
资助金额:$2.77万
-
财政年份:2013
-
负责人:THOMAS A GAZIANO
-
依托单位:
Global Cardiovascular Disease Policy Model for Screening Prevention and Treatment
-
批准号:8530270
-
项目类别:
-
资助金额:$62.58万
-
财政年份:2010
-
负责人:THOMAS A GAZIANO
-
依托单位:
Global Cardiovascular Disease Policy Model for Screening Prevention and Treatment
-
批准号:7949344
-
项目类别:
-
资助金额:$63.34万
-
财政年份:2010
-
负责人:THOMAS A GAZIANO
-
依托单位:
Global Cardiovascular Disease Policy Model for Screening Prevention and Treatment
-
批准号:8286373
-
项目类别:
-
资助金额:$63.21万
-
财政年份:2010
-
负责人:THOMAS A GAZIANO
-
依托单位:
Global Cardiovascular Disease Policy Model for Screening Prevention and Treatment
-
批准号:8130924
-
项目类别:
-
资助金额:$62.71万
-
财政年份:2010
-
负责人:THOMAS A GAZIANO
-
依托单位:
Cost-effective prevention of cardiovascular disease
-
批准号:6952009
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2004
-
负责人:THOMAS A GAZIANO
-
依托单位:
Cost-effective prevention of cardiovascular disease
-
批准号:7286322
-
项目类别:
-
资助金额:$11.48万
-
财政年份:2004
-
负责人:THOMAS A GAZIANO
-
依托单位:
Cost-effective prevention of cardiovascular disease
-
批准号:6863272
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2004
-
负责人:THOMAS A GAZIANO
-
依托单位:
Cost-effective prevention of cardiovascular disease in developing countries
-
批准号:7558039
-
项目类别:
-
资助金额:$12.31万
-
财政年份:2004
-
负责人:THOMAS A GAZIANO
-
依托单位:
Cost-effective prevention of cardiovascular disease
-
批准号:7110273
-
项目类别:
-
资助金额:$12.21万
-
财政年份:2004
-
负责人:THOMAS A GAZIANO
-
依托单位:
Cost-effective prevention of cardiovascular disease in developing countries
-
批准号:8010203
-
项目类别:
-
资助金额:$12.39万
-
财政年份:2004
-
负责人:THOMAS A GAZIANO
-
依托单位:
CARDIOMETABOLIC DISEASE & RISK FACTORS AMONG OLDER ADULTS IN SUB-SAHARAN AFRICA
-
批准号:8734315
-
项目类别:
-
资助金额:$21.23万
-
财政年份:--
-
负责人:THOMAS A GAZIANO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: